Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Emergent_BioSolutions> ?p ?o. }
Showing items 1 to 66 of
66
with 100 items per page.
- Emergent_BioSolutions abstract "Emergent BioSolutions (NYSE: EBS) is a multinational specialty biopharmaceutical company headquartered in Rockville, Maryland. It develops vaccines and therapeutics for infectious diseases, oncology and autoimmune disorders. The company has two divisions: a Biodefense division for counter-Anthrax products and a Biosciences division to treat some forms of autoimmune and inflammatory disorders and cancer. It was founded as BioPort Corporation in 1998, and renamed Emergent BioSolutions in 2004. Since the early 2000s, Emergent has expanded its product development, including research and development of products through joint ventures with its most well-known product being an anthrax vaccine.On August 2, 2013, Emergent acquired the Healthcare Protective Products Division (HPPD) of Bracco Diagnostics Inc. In doing so, Emergent acquired a product known as RSDL, which is a lotion used to decontaminate skin immediately after someone becomes exposed to certain chemical warfare agents.".
- Emergent_BioSolutions foundedBy Fuad_El-Hibri.
- Emergent_BioSolutions foundingYear "1998".
- Emergent_BioSolutions industry Pharmaceutical_drug.
- Emergent_BioSolutions locationCity Rockville,_Maryland.
- Emergent_BioSolutions locationCountry United_States.
- Emergent_BioSolutions netIncome "1.814E7".
- Emergent_BioSolutions product Anthrax_Vaccine_Adsorbed.
- Emergent_BioSolutions revenue "2.7338E8".
- Emergent_BioSolutions wikiPageExternalLink biothrax.com.
- Emergent_BioSolutions wikiPageExternalLink www.emergentbiosolutions.com.
- Emergent_BioSolutions wikiPageExternalLink quicktabs-newsroom.
- Emergent_BioSolutions wikiPageExternalLink emergent_biothrax_us.pdf.
- Emergent_BioSolutions wikiPageExternalLink ucm133822.htm.
- Emergent_BioSolutions wikiPageID "6262709".
- Emergent_BioSolutions wikiPageRevisionID "599539145".
- Emergent_BioSolutions areaServed "Worldwide".
- Emergent_BioSolutions caption "Emergent BioSolutions logo".
- Emergent_BioSolutions foundation "1998".
- Emergent_BioSolutions founder "Fuad El-Hibri".
- Emergent_BioSolutions hasPhotoCollection Emergent_BioSolutions.
- Emergent_BioSolutions industry Pharmaceutical_drug.
- Emergent_BioSolutions keyPeople "Daniel J. Abdun-Nabi, CEO & President".
- Emergent_BioSolutions locationCity Rockville,_Maryland.
- Emergent_BioSolutions locationCountry United_States.
- Emergent_BioSolutions logo "225".
- Emergent_BioSolutions name "Emergent BioSolutions".
- Emergent_BioSolutions netIncome "US$18.14 million".
- Emergent_BioSolutions products "BioThrax".
- Emergent_BioSolutions revenue "US$273.38 million".
- Emergent_BioSolutions subject Category:Biotechnology_companies_of_the_United_States.
- Emergent_BioSolutions subject Category:Companies_listed_on_the_New_York_Stock_Exchange.
- Emergent_BioSolutions subject Category:Pharmaceutical_companies_of_the_United_States.
- Emergent_BioSolutions type Abstraction100002137.
- Emergent_BioSolutions type BiotechnologyCompanies.
- Emergent_BioSolutions type Company108058098.
- Emergent_BioSolutions type DrugCompany108002578.
- Emergent_BioSolutions type Group100031264.
- Emergent_BioSolutions type Institution108053576.
- Emergent_BioSolutions type Organization108008335.
- Emergent_BioSolutions type PharmaceuticalCompanies.
- Emergent_BioSolutions type PharmaceuticalCompaniesOfTheUnitedStates.
- Emergent_BioSolutions type SocialGroup107950920.
- Emergent_BioSolutions type YagoLegalActor.
- Emergent_BioSolutions type YagoLegalActorGeo.
- Emergent_BioSolutions type YagoPermanentlyLocatedEntity.
- Emergent_BioSolutions type Agent.
- Emergent_BioSolutions type Company.
- Emergent_BioSolutions type Organisation.
- Emergent_BioSolutions type Organization.
- Emergent_BioSolutions type Agent.
- Emergent_BioSolutions type SocialPerson.
- Emergent_BioSolutions type Thing.
- Emergent_BioSolutions comment "Emergent BioSolutions (NYSE: EBS) is a multinational specialty biopharmaceutical company headquartered in Rockville, Maryland. It develops vaccines and therapeutics for infectious diseases, oncology and autoimmune disorders. The company has two divisions: a Biodefense division for counter-Anthrax products and a Biosciences division to treat some forms of autoimmune and inflammatory disorders and cancer. It was founded as BioPort Corporation in 1998, and renamed Emergent BioSolutions in 2004.".
- Emergent_BioSolutions label "Emergent BioSolutions".
- Emergent_BioSolutions label "Emergent BioSolutions".
- Emergent_BioSolutions sameAs Emergent_BioSolutions.
- Emergent_BioSolutions sameAs m.03p21bd.
- Emergent_BioSolutions sameAs Mx4rmQRRoiwJQdidyYcWB7j52w.
- Emergent_BioSolutions sameAs Q5370757.
- Emergent_BioSolutions sameAs Q5370757.
- Emergent_BioSolutions sameAs Emergent_BioSolutions.
- Emergent_BioSolutions wasDerivedFrom Emergent_BioSolutions?oldid=599539145.
- Emergent_BioSolutions homepage www.emergentbiosolutions.com.
- Emergent_BioSolutions isPrimaryTopicOf Emergent_BioSolutions.
- Emergent_BioSolutions name "Emergent BioSolutions".